RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
25.38
-1.18 (-4.44%)
Mar 31, 2025, 2:37 PM EDT - Market open
RxSight Market Cap
RxSight has a market cap or net worth of $1.03 billion as of March 31, 2025. Its market cap has decreased by -43.00% in one year.
Market Cap
1.03B
Enterprise Value
807.78M
1-Year Change
-43.00%
Ranking
Category
Stock Price
$25.38
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has increased from $424.33M to $1.03B, an increase of 142.18%. That is a compound annual growth rate of 27.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 1.08B | -22.39% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |